Conjunctival autograft for pterygium

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Kuo, Irene C ^a   Muthappan, Valliammai ^a   Wang, Xue ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN;

ADVERSE OUTCOME; AMNIOTIC MEMBRANE GRAFT; COMPARATIVE EFFECTIVENESS; CONJUNCTIVAL AUTOGRAFT; HEALTH CARE COST; HUMAN; PATIENT SAFETY; PEROPERATIVE CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PTERYGIUM; QUALITY OF LIFE ASSESSMENT; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TISSUE GRAFT; TREATMENT OUTCOME;

EID: 85041694387     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011349     Document Type: Review

References (26)

1. Barraquer J. The Cornea World Congress. Wathington: Butterworths, 1965.
2. Bultmann S, You L, Spandau U. Amniotic membrane down-regulates chemokine expression in human keratocytes. Investigative Ophthalmology & Visual Science 1999;40:S578.
3. Chen PP, Ariyasu RG, Kaza V, LaBree LD, McDonnell PJ. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. American Journal of Ophthalmology 1995;120(2):151-60.
4. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Current Opinion in Ophthalmology 1999;10(4):282-8.
5. D'Ombrain A. The surgical treatment of pterygium. British Journal of Ophthalmology 1948;32(2):65-71.
6. Droutsas K, Sekundo W. Epidemiology of pterygium. A review [Epidemiologie des pterygiums. Eine ubersicht]. Der Ophthalmologe 2010;107(6):511-6.
7. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19(3):348-52.
8. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
9. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989;3(Pt 2):218-26.
11. Karai I, Horiguchi S. Pterygium in welders. British Journal of Ophthalmology 1984;68(5):347-9.
12. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 1985;92(11):1461-70.
13. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14(5):473-84.
14. Kirwan JF, Constable PH, Murdoch IE, Khaw PT. Beta irradiation: new uses for an old treatment: a review. Eye 2003;17(2):207-15.
15. Klein S. [Zur operation des pterygium und zur transplantation von schleimhaut]. Allgemeine Wien Medizinischen Zeitung 1876;21:19.
16. Kobayashi A, Inana G, Meller D. Differential gene expression by human cultured umbilical vein endothelial cells on amniotic membrane. 4th Ocular Surface and Tear Conference, Miami, FL, USA. 14 May 1999.
17. Kwok LS, Coroneo MT. A model for pterygium formation. Cornea 1994;13(3):219-24.
18. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open 2013;3(11):1-8.
19. Prabhasawat P, Barton K, Burkett G, Tseng SC. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997;104(6):974-85.
20. Raj AKS. Clinical study to compare the incidence of recurrence after pterygium excision with bare sclera technique without intraoperative mitomycin C, with intraoperative mitomycin C application and conjunctival limbal autograft. Dissertation submitted to the Rajiv Gandhi University of Health Sciences, Karnataka, Bangalore 2010.
21. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
22. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. British Journal of Ophthalmology 1998;82(3):235-40.
23. Singh G. Pterygium and its Surgery. In: Smolin G, Foster CS, Azar DT, Dohlman CH editor(s). Smolin and Thoft's The Cornea: Scientific Foundations and Clinical Practice. Lippincott Williams and Wilkins, 2005:1001.
24. Solomon A, Monroy D, Ji Z. Suppression of epithelial expression of IL-1-beta by the amniotic membrane. 4th Ocular Surface and Tear Conference, Miami, FL, USA. 14 May 1999.
25. Tan CS, Lim TH, Koh WP, Liew GC, Hoh ST, Tan CC, et al.Epidemiology of pterygium on a tropical island in the Riau Archipelago. Eye 2006;20(8):908-12.
26. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. Journal of Cellular Physiology 1999;179(3):325-35.